Advanced search
Publication Cover
Channels Volume 12, 2018 - Issue 1
Submit an article Journal homepage
1,526
Views
24
CrossRef citations to date
0
Altmetric
Short Communication

CRMP2 is necessary for Neurofibromatosis type 1 related pain

Aubin MoutalDepartment of Pharmacology, University of Arizona, Tucson, AZ, USAORCID Iconhttp://orcid.org/0000-0003-4268-1206
ORCID Icon,
Song CaiDepartment of Pharmacology, University of Arizona, Tucson, AZ, USA
,
Shizhen LuoDepartment of Pharmacology, University of Arizona, Tucson, AZ, USA
,
Raphaëlle VoisinDepartment of Pharmacology, University of Arizona, Tucson, AZ, USA
&
Rajesh KhannaDepartment of Pharmacology, University of Arizona, Tucson, AZ, USA;Department of Anesthesiology, University of Arizona, Tucson, AZ, USA;Neuroscience Graduate Interdisciplinary Program, College of Medicine, University of Arizona, Tucson, AZ, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-9066-2969
ORCID Icon
Pages 47-50 | Received 18 Aug 2017, Accepted 18 Aug 2017, Published online: 17 Jan 2018

References

  • Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89:1-6. [doi:10.1002/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8] PMID:10469430
  • Hegedus B, Dasgupta B, Shin JE, Emnett RJ, Hart-Mahon EK, Elghazi L, Bernal-Mizrachi E, Gutmann DH. Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms. Cell Stem Cell. 2007;1:443-57. [doi:10.1016/j.stem.2007.07.008] PMID:18371380
  • Molosh AI, Johnson PL, Spence JP, Arendt D, Federici LM, Bernabe C, Janasik SP, Segu ZM, Khanna R, Goswami C et al. Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase. Nat Neurosci. 2014;17:1583-90. [doi:10.1038/nn.3822] PMID:25242307
  • Noll RB, Reiter-Purtill J, Moore BD, Schorry EK, Lovell AM, Vannatta K, Gerhardt CA. Social, emotional, and behavioral functioning of children with NF1. Am J Med Genet A. 2007;143A:2261-73. [doi:10.1002/ajmg.a.31923] PMID:17726688
  • Garg S, Lehtonen A, Huson SM, Emsley R, Trump D, Evans DG, Green J. Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study. Dev Med Child Neurol 2013;55:139-45. [doi:10.1111/dmcn.12043] PMID:23163236
  • Walsh KS, Velez JI, Kardel PG, Imas DM, Muenke M, Packer RJ, Castellanos FX, Acosta MT. Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1. Dev Med Child Neurol. 2013;55:131-8. [doi:10.1111/dmcn.12038] PMID:23163951
  • Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans DG, Huson SM. Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics. 2013;132:e1642−8. [doi:10.1542/peds.2013-1868] PMID:24190681
  • Omrani A, van der Vaart T, Mientjes E, van Woerden GM, Hojjati MR, Li KW, Gutmann DH, Levelt CN, Smit AB, Silva AJ et al. HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1. Mol Psychiatry. 2015;20:1311-21. [doi:10.1038/mp.2015.48] PMID:25917366
  • Moutal A, Dustrude ET, Khanna R. Sensitization of Ion Channels Contributes to Central and Peripheral Dysfunction in Neurofibromatosis Type 1. Mol Neurobiol. 2017;54:3342-9. [doi:10.1007/s12035-016-9907-1] PMID:27167129
  • Drouet A, Wolkenstein P, Lefaucheur JP, Pinson S, Combemale P, Gherardi RK, Brugières P, Salama J, Ehre P, Decq P et al. Neurofibromatosis 1-associated neuropathies: a reappraisal. Brain: a journal of neurology. 2004;127:1993-2009. [doi:10.1093/brain/awh234] PMID:15289270
  • Creange A, Zeller J, Rostaing-Rigattieri S, Brugieres P, Degos JD, Revuz J, Wolkenstein P. Neurological complications of neurofibromatosis type 1 in adulthood. Brain: a journal of neurology. 1999;122 (Pt 3):473-81. [doi:10.1093/brain/122.3.473] PMID:10094256
  • Moutal A, Yang X, Li W, Gilbraith KB, Luo S, Cai S, François-Moutal L, Chew LA, Yeon SK, Bellampalli SS et al. CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1 (NF1)-related pain that is reversed by (S)-Lacosamide. Pain. 2017 Jul 3. doi:10.1097/j.pain.0000000000001002.[Epub ahead of print]
  • Moutal A, Dustrude ET, Largent-Milnes TM, Vanderah TW, Khanna M, Khanna R. Blocking CRMP2 SUMOylation reverses neuropathic pain. Molecular psychiatry. 2017. [doi:10.1038/mp.2017.117]
  • Moutal A, Wang Y, Yang X, Ji Y, Luo S, Dorame A, Bellampalli SS, Chew LA, Cai S, Dustrude ET et al. Dissecting the role of the CRMP2-Neurofibromin complex on pain behaviors. Pain. 2017. [doi:10.1097/j.pain.0000000000001026]
  • Heckl D, Kowalczyk MS, Yudovich D, Belizaire R, Puram RV, McConkey ME, Thielke A, Aster JC, Regev A, Ebert BL et al. Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing. Nat Biotechnol. 2014;32:941-6. [doi:10.1038/nbt.2951] PMID:24952903
  • Dustrude ET, Moutal A, Yang X, Wang Y, Khanna M, Khanna R. Hierarchical CRMP2 posttranslational modifications control NaV1.7 function. Proc Nat Acad Sci U S A. 2016; 113:E8443−E52. [doi:10.1073/pnas.1610531113] PMID:27940916
  • Brittain JM, Piekarz AD, Wang Y, Kondo T, Cummins TR, Khanna R. An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels. J Biol Chem. 2009;284:31375-90. [doi:10.1074/jbc.M109.009951] PMID:19755421
  • Balastik M, Zhou XZ, Alberich-Jorda M, Weissova R, Ziak J, Pazyra-Murphy MF, Cosker KE, Machonova O, Kozmikova I, Chen CH et al. Prolyl Isomerase Pin1 Regulates Axon Guidance by Stabilizing CRMP2A Selectively in Distal Axons. Cell Rep. 2015; 13:812-28. [doi:10.1016/j.celrep.2015.09.026] PMID:26489457

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.